COMPANY

Ingenia Therapeutics

Profile checked Oct 10, 2026

Keywords: Chronic Kidney Disease IGT-303

Timeline

Oct 30, 2025 Trial start Phase 1/Phase 2: A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease source ↗

2026-12 (ESTIMATED) · Phase 1/Phase 2 · A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease · NCT07231679

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT07231679	A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease	Phase 1/Phase 2	Recruiting	Oct 30, 2025	2026-12 (estimated)